The 2010 Quantitative Imaging Cytometry Symposium will be held on August
10-12 in Boston, Massachusetts, hosted by the International QIC Center at
Children¹s Hospital Boston, an affiliate of Harvard Medical School.  The
three-day symposium and advanced practical workshops will present an
excellent and diverse scientific information exchange.
 
Registration is now open at
http://www.imagingcytometrycenter.com/BostonAgendaiQIC.htm
<http://www.imagingcytometrycenter.com/BostonAgendaiQIC.htm> .  As in
previous years, this symposium is expected to be over-subscribed. Prompt
registration is advised to assure space availability.
 
Symposium presentations will include the following:
 
Imaging Cytometry: An Expanding Role in Biomedical Imaging Analysis ­
William Telford, PhD, National Cancer Institute, National Institutes of
Health, Bethesda, MD
 
Spatial Analysis of Hematopoietic Stem and Progenitor Cells in Bone Marrow ­
Leslie Silberstein, MD, Children's Hospital Boston, Dana-Farber Cancer
Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
 
Combinatorial Development of Biomaterials for Tissue Engineering and Drug
Delivery ­ Daniel Anderson, PhD, David H. Koch Institute for Integrative
Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
 
The iCys® Imaging Cytometer in the Epigenetic Toolbox for Autism Research ­
Janine LaSalle, PhD, UC Davis School of Medicine, Davis, CA.
 
Assessment of DNA Damage by High-Resolution Cytometry ­ Zbigniew
Darzynkiewicz, MD, PhD, Brander Cancer Research Institute, Valhalla, NY
 
Advanced Cell Cycle Analysis ­ James Jacobberger, PhD, Case Western Reserve
University and Case Comprehensive Cancer Center, Cleveland OH
 
The Untapped Potential of Laser Scanning Cytometry in Genome Damage,
Proteome and Nutritional Diagnostics at the Single Cell and Sub-Type Level ­
Michael Fenech, PhD, CSIRO Food and Nutrition Sciences, Commonwealth
Scientific and Industrial Research Organisation, Adelaide, Australia
 
Potential Mechanisms for the Generation of Chromosome Aneuploidy in Human
Cancer ­ 
John M. Lehman, PhD, Brody School of Medicine, East Carolina University,
Greenville, NC
 
Application of Imaging Cytometry to the Molecular Therapeutics of Human
Solid Tumors ­ 
David Hedley, MD, Ontario Cancer Institute, University Health Network,
Toronto, ON, Canada
 
Leveraging Quantitative Imaging Cytometry to Measure the Pharmacodynamic
Impact of Drugs in Development ­ Gloria Juan, PhD, Amgen, Thousand Oaks, CA
 
Quantitative Imaging Cytometry for the Diagnostic Pathologist:  What Does
the Laser Scatter Imaging Component Add? ­ William Geddie, MD, University
Health Network/Toronto General Hospital, Toronto ON, Canada
 
Mislocalization of APAFI as a Novel Diagnostic and Prognostic Marker for
Refractory Diffuse B-Cell Lymphoma? ­ Shazib Pervaiz, MBBS, PhD, National
University of Singapore and Duke-NUS GMS
 
Capturing Signaling Events in the Immune System in Situ ­ Margaret Harnett,
PhD, Glasgow Biomedical Research Centre, University of Glasgow, Scotland, UK
 
Afternoon workshops include the following:
 
Cytome Diagnostics (Instructor:  Michael Fenech, PhD, CSIRO Food and
Nutrition Sciences
Adelaide, Australia)
 
Quantitative Assessment of Pancreatic Islets
(Instructor: David Krull, GlaxoSmithKline, Research Triangle Park, NC)
 
Advanced Cell Cycle Analysis (Instructors:  James Jacobberger, PhD and Tammy
Stefan, Case Comprehensive Cancer Center, Cleveland, OH)
 
Immunophenotyping in FNAs (fine needle aspirates)  (Instructor:  William
Geddie, MD, UHN/Toronto General Hospital, Toronto, ON, Canada)
 
Analysis of Drug-Induced DNA Damage  (Instructor: Shazib Pervaiz, National
University of Singapore and Duke-NUS GMS, and Andrea Holme, National
University of Singapore)
 
Quantitative Imaging of Bone Marrow Microenvironment (Instructors: César
Nombela-Arrieta, PhD and Shin-Young Park, PhD, Children¹s Hospital Boston,
Boston, MA)